COVID-19 vaccination is associated with enhanced efficacy of anti-PD-(L)1 immunotherapy in advanced NSCLC patients: a real-world study

Coronavirus disease 2019 (COVID-19) vaccine has played a major role in ending the pandemic. However, little is known about the influence of COVID-19 vaccine on the efficacy of immunotherapy in patients with no...

Source: Infectious Agents and Cancer - September 7, 2023 Category: Cancer & Oncology Authors: Yunfei Qian, Zhuxian Zhu, Yin-Yuan Mo and Ziqiang Zhang Tags: Research Source Type: research